home
about us
related links
our team
leadership
staff
affiliates
our services
our clients
our experience
presentations
aptuit consulting overview
accelerating availability of new drugs for patients with serious disease
pharmaceutical salts and obviousness
implementing a preclinical program for biotechnology derived proteins
investigational new drug applications; same information different formats (us/eu)
application of 'omics technologies and pathway biology in pharmaceutical development
white papers
publications
animations
careers
offices
news
contact us
Strategic Planning
Manufacturing
PreClinical
Regulatory
Clinical
GxP Quality/Compliance
Patent Support
Counterfeit Analysis
Asset Evaluation
Accelerating Availability of New Drugs for Patients with Serious Disease
02.22.2008
Presented at the Massachusetts Biotech Council
by William M Mackin PhD, RAC (US)
Click here
to view full presentation